Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving Dialysis
NCT00094484 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 400
Last updated 2013-05-08
Summary
The purpose of this study is to evaluate the efficacy and safety of cinacalcet compared with placebo in patients with stage 3 and 4 Chronic Kidney Disease (CKD).
Conditions
Interventions
- DRUG
-
Cinacalcet HCl
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
MD · Amgen
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-10-31
More Related Trials
-
Study to Evaluate Cinacalcet in Children With Chronic Kidney Disease
NCT01290029 ·Status: COMPLETED ·Phase: PHASE1
-
Cinacalcet Study to Reach Kidney Disease Outcomes Quality Initiative (K/DOQI) Levels
NCT00113958 ·Status: COMPLETED ·Phase: PHASE2
-
Compare the Efficacy of Cinacalcet vs Traditional Vitamin D for Secondary Hyperparathyroidism (SHPT) Among Subjects Undergoing Hemodialysis
NCT01181531 ·Status: COMPLETED ·Phase: PHASE4
-
Head-to-Head Study of Etelcalcetide (AMG 416) and Cinacalcet
NCT01896232 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
NCT00975000 ·Status: COMPLETED ·Phase: PHASE3
-
Extension Study of Cinacalcet for Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Patients With Chronic Kidney Disease on Dialysis
NCT02341417 ·Status: COMPLETED ·Phase: PHASE3
-
Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
NCT00446329 ·Status: TERMINATED ·Phase: PHASE4
-
Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism
NCT01439867 ·Status: TERMINATED ·Phase: PHASE2
-
A Research Study for Patients With End-Stage Renal Disease (ESRD)
NCT00110890 ·Status: COMPLETED ·Phase: PHASE4
-
SENSOR: Study to Investigate Cinacalcet Treatment in Haemodialysis Patients With Secondary Hyperparathyroidism
NCT00117052 ·Status: COMPLETED ·Phase: PHASE3
-
Bone Markers and Bone Density Changes in Hyperperparathyroid Dialysis Patients Under Cinacalcet Treatment
NCT04637360 ·Status: COMPLETED ·Phase: NA
-
Cinacalcet stUdy for Peritoneal Dialysis Patients In Double Arm on the Lowing Effect OF iPTH Level
NCT01101113 ·Status: COMPLETED ·Phase: PHASE4
-
Using Cinacalcet to Treat the Hypophosphatemia of Early Kidney Transplant
NCT01011114 ·Status: TERMINATED ·Phase: NA
-
Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Patients With Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy
NCT00975221 ·Status: COMPLETED ·Phase: PHASE3
-
Cinacalcet in Management of Secondary Hyperparathyroidism in Haemodialysis Patients
NCT02338934 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Assess the Efficacy and Safety of Paricalcitol in the Treatment of Chronic Kidney Disease With Secondary Hyperparathyroidism
NCT04994080 ·Status: UNKNOWN ·Phase: PHASE3
-
Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients
NCT00415584 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Cinacalcet Versus Parathyroidectomy in Peritoneal Dialysis Patients
NCT01447368 ·Status: COMPLETED ·Phase: PHASE4
-
Cinacalcet in Paediatric Secondary Hyperparathyroidism (SHPT) Due to Chronic Kidney Disease (CKD)
NCT01479088 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Safety, Pharmacokinetics, and Clinical Effects of Cinacalcet (AMG 073) in Primary Hyperparathyroidism
NCT03774771 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of a Cincalcet Suppression Test
NCT01103206 ·Status: COMPLETED ·Phase: PHASE4
-
Pediatric Chronic Kidney Disease Safety and Efficacy
NCT01277510 ·Status: TERMINATED ·Phase: PHASE3
-
Study to Assess the Impact on Calcium Levels When Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT) Switch From Cinacalcet to Etelcalcetide
NCT01932970 ·Status: COMPLETED ·Phase: PHASE3
-
Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism
NCT07122401 ·Status: RECRUITING ·Phase: PHASE3
-
Sevelamer and Secondary Hyperparathyroidism in Chronic Kidney Disease
NCT01191762 ·Status: COMPLETED ·Phase: PHASE3